(Q34321128)

1 August 2017

1 reference

title

The nonmedical use of ketamine, part two: A review of problem use and dependence (English)

1 reference

1 August 2017

Jansen KL

1

1 reference

1 August 2017

Darracot-Cankovic R

series ordinal

2

1 reference

1 August 2017

publication date

1 April 2001

1 reference

Journal of Psychoactive Drugs

1 August 2017

published in

1 reference

1 August 2017

volume

33

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

151-158

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

1 August 2017

1 reference

Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

The development of an acute tolerance to ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

A review of the nonmedical use of ketamine: use, users and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Ecstasy (MDMA) dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Effect of NMDA antagonists on development of rapid tolerance to various barbiturates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Effect of NMDA antagonists on rapid tolerance to benzodiazepines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Effect of NMDA antagonists on rapid tolerance to ethanol under two different testing paradigms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Ketamine psychedelic therapy (KPT): a review of the results of ten years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Ketamine tolerance and hallucinations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Development of EEG seizure activity during and after chronic ketamine administration in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Differential effects of ketamine on schedule-controlled responding and motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Magnesium deficiency increases ketamine sensitivity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Psychotomimesis mediated by kappa opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Ketamine attenuates and reverses morphine tolerance in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

The interaction of ketamine with the opiate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

A second endogenous cannabinoid that modulates long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

Phencyclidine and ketamine: Comparison with the effect of cocaine on the noradrenergic neurones of the rat brain cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2001.10400480

10.1080/02791072.2001.10400480

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference